Novartis Has Blockbuster Drugs Coming: Rundquist

April 24 (Bloomberg) -- Odile Rundquist, senior pharmaceutical analyst at Helvea, talks with Manus Cranny about first-quarter results at Novartis AG and examines the overall pharmaceutical market. She speaks on Bloomberg Television's "On The Move."
Fitbit Looks to Raise $478 Million in IPO
17:47 - Fitbit is seeking to raise as much as $478 million in an initial public offering. Bloomberg's Drew Armstrong reports on “Bloomberg Markets.” (Source: Bloomberg)
  • Human Error Not Ruled Out in Amtrak Crash
  • Dow Lower: Energy Leads, Utilities Lag
  • Honda's May U.S. Car Sales Rise 1.3%